Vervolg zonder link opsomming

• About MEB
• Human Medicines
• Veterinary Medicines
• Novel Foods

• News
• Comprehensible package leaflets
• Medicinal Products
  • Marketing Authorisation
  • Side effects & DHPCs
  • Package leaflets
  • Allergy information
  • Paediatric medicinal products
  • Branded or generic
  • Off-label-use
  • Public Assessment Reports
  • Prescription or non-prescription
• Pharmacovigilance
  • Direct healthcare professional communications (DHPC's)
  • Periodic Safety Update Reports (PSURs)
  • Reporting adverse events
  • Risk Management Plan (RMP)
• Regulatory Affairs
  • eSubmission
  • Forms
  • Generic medicinal products
  • Legislation & guidelines
  • Marketing authorisation via Decentralised and Mutual recognition procedures
  • Marketing authorisation via centralised procedure
  • Marketing authorisation via National procedure
  • Class Labelling
  • Over-the-counter medicinal products
  • Compassionate use programme
  • Products & fees 2010
  • Package leaflets, SPC and labelling
  • Scientific advice
  • Specific product categories
  • Good manufacturing practice (GMP)
  • Variations
• Homeopathy
  • Assessments
  • Register
  • Side effects
  • Package leaflets, spc and labelling
  • Dossier advice
  • Homeopathic Drug Master File (HDMF)
  • Legislation
• Herbal Medicinal Products
  • Register
  • Package leaflets
  • Assessments
• Publications
• Medical devices
  • Fees
  • Procedure & dossier requirements
• Consumers
  • Meeting with patient and consumer organisations
• Database human medicines
• Frequently Asked Questions

Back